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The finding that certain somatic cells can be directly converted into
cells of other lineages by the delivery of specific sets of transcrip-
tion factors paves the way to novel therapeutic applications. Here
we show that human cord blood (CB) CD133+ cells lose their
hematopoietic signature and are converted into CB-induced neu-
ronal-like cells (CB-iNCs) by the ectopic expression of the transcrip-
tion factor Sox2, a process that is further augmented by the
combination of Sox2 and c-Myc. Gene-expression analysis, immu-
nophenotyping, and electrophysiological analysis show that CB-
iNCs acquire a distinct neuronal phenotype characterized by the
expression of multiple neuronal markers. CB-iNCs show the ability
to fire action potentials after in vitro maturation as well as after
in vivo transplantation into the mouse hippocampus. This system
highlights the potential of CB cells and offers an alternative means
to the study of cellular plasticity, possibly in the context of drug
screening research and of future cell-replacement therapies.
neurons | reprogramming | stem cells
The fate of adult somatic cells is not fixed rigidly and can bereprogrammed by experimental manipulation. The generation
of induced pluripotent stem cells (iPSCs) represents the most
dramatic evidence that the epigenome of somatic cells are re-
markably plastic (1).Recently, it has been reported that fibroblasts
can be converted by ectopic expression of defined transcription
factors into postmitotic neurons (2–9), neural progenitors (10, 11),
and self-renewing neural stem cells (NSCs) (12, 13). However,
most reported methods rely on the use of multiple transcription
factors and the use of fibroblasts as donor cells.
Here we investigate if cord blood (CB) stem cells can be in-
duced to acquire a neuronal phenotype by using only one tran-
scription factor. It has been previously shown that stem cell
populations are more amenable to reprogramming than other
somatic cells, probably as a result of their preexisting epigenetic
state (14, 15). Moreover, because of their biological character-
istics and availability, CB cells as a donor cell type could offer
clear logistic advantages vs. other adult somatic cell types (16,
17). These cells can be collected without any risk for the donor
and are young cells carrying minimal somatic mutations.
Strikingly, we show that forced expression of Sox2 is sufficient
to convert CB CD133+ cells into induced neuronal progenitor
(NP)-like cells, a conversion process that is augmented by the
coexpression of c-Myc. Sox2 is highly expressed in adult NSCs, is
one of the earliest functional markers of neuroectodermal
specification in the embryo, and plays a key role in the neural
lineage specification (18–20). We show that Sox2-transduced CB
cells acquire a distinct neuronal morphology and express multi-
ple neuronal markers in vitro, and that they can be expanded for
as many as 25 passages when cultured in permissive condition
culture. Moreover, we show that CB-induced neuronal-like cells
(CB-iNCs) are able to differentiate in vitro and in vivo into
mature neurons that generate action potentials. Our findings
provide a proof of principle that human blood cells can be
converted into iNCs and offer a complementary paradigm for
investigating the molecular mechanisms that underlie direct
lineage conversion between somatic cell types.
Results
Sox2 Is Sufficient for Conversion of CB CD133+ Cells into CB-iNCs. CB
CD133+ cells were isolated by using CD133 immunoselection
(purity range of 92–97%; Fig. S1A) and infected with Sox2 ret-
roviral vector (infection efficiency, 20–30%; Fig. S1B). To ex-
clude the presence of contaminating rare NP or neural crest
(NC) cells within the starting population, we performed an ex-
tensive characterization of CD133+ fraction by quantitative real-
time (qRT)-PCR and immunocytochemistry. In agreement with
previous data, CB CD133+ cells were negative or showed a very
low level of early neural markers such as Mash1, Nkx2.2, Sox1,
Pax6, Nestin, Otx1, Otx2, NeuroD1, and Doublecortin (Dcx)
(21) (Fig. S2 A and B). Although low levels of mRNA of Sox10
and Snail were observed in a few samples, we could not detect
any cells positive for SOX10 or the low-affinity neurotrophin
receptor p75NRT by immunofluorescence or FACS analysis
(Fig. S2 C–E). CB CD133+ cells were also negative for other NC
markers such as Slug, Ngn1, and Pax3 (Fig. S2 C and D).
Moreover, CD133+ cells did not spontaneously give rise to
neuronal cells when maintained under neural culture conditions
for a long period (21, 22).
Our initial attempts to convert Sox2-infected CB cells into
neurons by using standard neural condition cultures were un-
successful and infected CD133+ cells underwent apoptosis. In-
stead, we found that coculture with irradiated human foreskin
fibroblasts (i.e., HFF-1 cells) in the presence of bFGF (23) (Fig.
1A) were permissive for the survival of Sox2-transduced CB cells.
By 3 wk after infection, these conditions led to the appearance of
one or two colonies from 3 × 104 CD133+ cells infected (con-
version efficiency of 0.004–0.008%). Despite numerous attempts
in parallel, we were unable to derive colonies by using the
CD133-negative fraction of CB.
Immunocytochemistry analysis showed that the colonies at the
earliest passage (i.e., passage 0) were negative for the pluripotency
markers OCT4, NANOG, SSEA3, TRA-1–60, and TRA-1–81, as
well as alkaline phosphatase (ALP; Fig. 1B and Fig. S3A). Instead,
cells positive for neural progenitor markers TUJ-1, PAX6, and
DCX were observed, although the resulting cells showed an im-
mature neuronal morphology (Fig. S3A). To gain insight into
whether the conversion process occurs by first passing through an
intermediate pluripotent state (10, 24), infected CB CD133+ cells
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were evaluated for the expression of TRA-1–60 and TRA-1–81 at
different time points during the conversion process [days (d) 7,
d13, and d17]. As shown in Fig. S3B, no cells positive for these
pluripotency markers were detectable.
Interestingly, after a few passages, the colonies acquired a more
complex cytoarchitecture (Fig. 1B). Colonies at passage 2 were
already composed of cells with a typical neuronal morphology and
expressed TUJ-1, Neurofilament (NF), and microtubule-associ-
ated protein 2 (MAP2; Fig. 1C). In addition, the absence of OCT4
andNANOGwas confirmed at this stage (Fig. 1C).Upon injection
into immune-compromised SCID mice, the colonies at early pas-
sages failed to generate intratesticular teratoma (Fig. S3C), fur-
ther suggesting that the conversion process was direct. Next, we
observed that coinfecting CB cells with Sox2 and c-Myc increased
the frequency of colonies by 15- to 25-fold (conversion efficiency,
0.06–0.1%; Fig. 1D). Thus, although c-Myc is not formally re-
quired for the neural conversion process, it does enhance its effi-
ciency dramatically (25). This is in accordance with the known role
of c-Myc in controlling the self-renewal and proliferation of neural
progenitor cells (26–28). Consistently, we confirmed that Sox2/c-
Myc-induced colonies highly expressed TUJ-1, MAP2, DCX, and
PAX6 (Fig. 1E). In particular, the expression of TUJ-1, NeuroD1,
and DCX was predominant and homogeneous in all the clones,
whereas a minor variability was observed in the expression level of
MAP2, NF, and PAX6 among different clones (Fig. S4A). Amore
extensive characterization of these colonies revealed the lack of
expression of early neural markers Nkx2.2, Musashi1, Mash1, and
Sox1, whereas low level of expression of Nestin was detected.
Moreover, little or no expression of other postmitotic neural
markers was seen (NeuN, VGlut1, GABA, and Synapsin1) when
colonies were cultured in the presence of bFGF. Finally, no
astrocytes or oligodendrocytes were detected under these culture
conditions as assessed by GFAP, S100b, OLIG1, PDGFRa, and
NG2 immunostaining (Fig. S4 A and B). Accordingly, when the
colonies were disaggregated and replated as single cells onto
matrigel-coated plates in neuronal medium, the cell population
comprised 44% TUJ-1+ cells and 21% PAX6+ cells (Fig. S4C),
indicative of an intrinsic bias of these cells toward neuronal dif-
ferentiation. Thus, these data show that Sox2 and c-Myc in com-
bination with permissive culturing conditions drive the conversion
of CB CD133+ cells into a heterogeneous population of CB-iNCs
at different levels of neuronal specification and maturation.
CB-iNCs Show Proliferative Activity and Can Be Propagated in Defined
Condition Culture. Interestingly, we observed that CB-iNCs could
be expanded and maintained in culture on top of HFF-1 and in
the presence of bFGF for many passages, without losing their
neuronal phenotype (tested for as many as 25 passages). Ac-
cordingly, BrdU incorporation along with Ki67 staining showed
that the colonies comprised proliferative DCX+/TUJ-1+ cells
(Fig. S5A).
In an attempt to enrich the proliferating neural progenitors
present within CB-iNCs, we performed single-cell clonal assay and
observed the presence of a small number of clonogenic cells
(∼8%), responsible for colony formation. In particular, when CB-
iNCs were seeded as single cells on HFF-1 and in the presence of
bFGF, we observed the generation of adherent neural epithelium-
like colonies (Fig. S5B). These cells could be continuously pas-
saged (up to passage 6, at time of manuscript submission) and
showed a fast cycling profile when transferred on matrigel and
cultured in the presence of bFGF (Fig. S5C). Immunostaining
revealed that these cells homogeneously expressed early neural
progenitor markers NESTIN and SOX2, and the proliferating
marker Ki67 (Fig. S5D). Accordingly, qRT-PCR analysis showed
a down-regulation of markers of more committed neural cells
(NeuroD1 and MAP2) and confirmed the up-regulation of early
neural markers (Mash1 and Nestin) when these cells were com-
pared with CB-iNCs. In addition, we observed a significant up-
regulation of endogenous Sox2, whereas the exogenous Sox2 be-
came silenced (Fig. S6A). Interestingly, the up-regulation of
neural progenitor markers and endogenous Sox2, as well as the
silencing of the transgene, became more pronounced, when the
clonal adherent CB-iNCs were cultured under a chemically de-
fined condition previously shown to promote self-renewal of
primitive neural precursors (29). Together these data suggest that
CB-iNCs contain a small population of early NP-like cells that are
capable of self-renewal and have undergone epigenetic changes
that reactivated master regulators of neural progenitor fate.
We successfully repeated the experiments with 15 independent
CB units by using the two conditions (Sox2 alone and Sox2/c-
Myc) and generated 40 CB-iNC lines. Cytogenetic analysis
showed that the CB-iNCs lines maintained a normal 46,XY or
46,XX karyotype after more than 15 passages (Fig. S6B). Eigh-
teen lines were expanded and characterized for expression of
neural markers. Furthermore, seven independent CB-iNC lines
were further differentiated into mature neuronal cells and ex-
plored for neural activity in vitro and in vivo.
CB-iNCs Differentiate and Show Mature Neuronal Properties. To test
their ability to derive functional neurons, CB-iNCs were dis-
aggregated and replated as single cells onto polyornithine/lam-
inin-coated plates or in coculture with human astrocytes, in the
presence of neural differentiation medium, for 4 to 6 wk as
previously described (30). Although we found that CB-iNCs
under both culture conditions acquired morphology typical of
Fig. 1. Images related to CB-iNCs derivation and characterization. (A) Time-
line of CB CD133+ stem cell conversion into neuronal-like cells. (B) Represen-
tative phase-contrast images of passage-0 and passage-2 CB-iNCs generated
by overexpression of only Sox2 and relative alkaline phosphatase (AP) staining.
(C) Sox2 CB-iNCs expressed TUJ-1, microtubule-associated protein 2 (MAP2),
and NF but were negative for OCT4 and NANOG. Blue indicates nuclei stained
with DAPI. (Scale bars: Upper, 50 μm; Lower, 100 μm.). (D) Representative
phase contrast images of passage-0 and passage-2 CB-iNCs generated with
Sox2 and c-Myc and relative AP staining. (E) The colonies contained neuronal
cells positive for TUJ-1, MAP2, PAX6, and DCX. Blue indicates nuclei stained
with DAPI. (Scale bar, 50 μm.)








mature neurons, the use of astrocyte feeders seemed more ef-
fective in directing the maturation and expression of proteins
involved in synaptic transmission. After 1 mo, the cells showed
MAP2-positive dendrites with distinct vesicular glutamate
transporter-1 (VGLUT1) puncta (Fig. 2A) or, alternatively,
TUJ-1+ processes expressed inhibitory GABAergic markers
(Fig. 2B). In addition, the appearance of Synapsin puncta on
TUJ-1–positive cells highlighted the presence of mature synaptic
buttons on CB-derived neurons (Fig. 2C). Thus, the presence of
Synapsin-positive terminals suggested that these neurons in
culture were mature, and the expression of VGLUT1 and GABA
markers indicated the presence of inhibitory and excitatory
neurons. We successfully repeated the in vitro differentiation of
CB-iNCs into neurons by using clones at early and late passages
(5–15), without observing any significant difference.
Next, to further characterize the CB-iNCs at the molecular
level, we performed a global gene expression analysis on CB-
iNCs colonies, CB-derived neurons, and the starting population
of selected CB CD133+ cells. Because finding an appropriated
positive control is usually difficult when working with human
samples, we used human ES (hES)-derived (HUES6)-NPCs and
HUES6-neurons as points of reference (30). Consistent with
their neuronal phenotypes, CB-iNCs and CB-neurons clustered
with HUES6-NPCs and HUES6-neurons rather than with their
CD133+ cells of origin (Fig. 2 D and E). A set of neuronal-
specific genes comprising Map2, Pax6, NF, NeuroD1, Ncam1,
VGlut1, Map1B, and Synapsin1 was found significantly up-reg-
ulated (twofold change; P < 0.05) in CB-iNCs and CB-derived
neurons in comparison with the starting population CB CD133+
cells (Fig. 2E). As controls, the down-regulation of hematopoi-
etic-specific genes (CD34, CD38, CD31, CD45, Flt3, and Gata2)
in CB-iNCs indicated that they had undergone an erasure of their
hematopoietic transcriptional profile.
To gain further insights into the underlying mechanism of the
role of Sox2 during the conversion process, we investigated
whether genes up-regulated in CB-iNCs, which are known to have
potential SOX2 binding sites (19, 31), were also bound by SOX2
in CB-iNCs. By using ChIP, we found evidence that SOX2 binds
the NeuroD1, Dcx, Nav2, Mash1, and Chd7 genes (Fig. 2F).
We performed Southern blot analysis of genomic DNA and
confirmed the independent origin of our CB-iNCs and showed a
maximum of two integrations per retrovirus and genome in all CB-
iNCs clones analyzed (Fig. S7A). qRT-PCR analysis showed that
exogenous Sox2 and c-Myc were expressed in CB-iNCs colonies,
although, following neuronal differentiation, we observed a sig-
nificant down-regulation of the retroviral transgenes (Fig. S7B).
Fig. 2. Characterization and gene-expression profile of
CB-derived neurons. (A) CB-iNCs after 6 wk of differentia-
tion on top of human astrocytes acquired a more mature
phenotype highlighted by the expression of the excitatory
markers VGLUT1 and the dendritic marker MAP2. (Scale
bar, 30 μm.) (B) CB-derived neurons were positive for in-
hibitory markers such as GABA. (Scale bar, 80 μm.) (C)
Synaptic buttons on CB-derived neurons were highlighted
by the expression of synapsin puncta on TUJ-1–positive
cells. (Scale bar, 10 μm.) (D) Heat map of genes differen-
tially expressed in microarray analysis performed on CB
CD133+ cells, CB-iNCs, and CB-derived neurons. Human ES-
derived (HUES6) NPCs and HUES6-derived neurons were
used as points of reference for neuronal phenotype. (E)
Average global gene expression patterns were compared
between CB CD133+ (n = 3 replicates) CB-iNCs (n = 3 repli-
cates), CB-derived neurons (n = 3 replicates), and HUES6-
NPCs (n = 2 replicates). Some neural-specific genes are
highlighted in the plots (Map1, Map2, VGlut1, Pax6, NF,
NeuroD1, Ncam, and Synapsin1). We found up-regulation
of Fez1, Tead2, and NNAT, typical markers for dorsal neu-
rons. (F) ChIP assay shows SOX2 binding to the regulatory
regions of the indicated genes. Levels were determined by
quantitative PCR and are expressed as fold change vs. the
input. The positions of the amplicons are indicated in kil-
obases from the transcription start site (TSS). The mean and
SD of three independent experiments is shown.
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To assess whether the CB-iNCs can be stably maintained
without continued transgene expression, we used a doxycycline-
inducible strategy to generate CB-iNCs (Fig. S7 C–E). The col-
onies were then cultured in the presence of bFGF but with
decreasing doxycycline concentrations. These data showed that
CB-iNCs achieved a stable neuronal state independent of viral
transgene expression and could be expanded as many as 15
passages after doxycycline withdrawal without loss of the neu-
ronal phenotype (Figs. S7E and S8 A and B). We confirmed the
presence of mitotic Ki67+/TUJ-1+/DCX+ cells in the complete
absence of transgene activity (Fig. S8C).
CB-Derived Neurons Show Synaptic Activity in Vitro. Electrical cell
activity leads to increases in intracellular calcium levels and ac-
tivation of signaling pathways that are important for the regu-
lation of processes in neurons (32). First, to test if CB-derived
neuronal networks were functionally capable of generating cal-
cium transients, we preloaded the cells with the calcium indicator
fluo-4AM and highlighted neurons using the Synapsin::DsRed
reporter (Fig. 3A). Cultures with similar density and number of
DsRed-positive neurons were used. Spontaneous calcium tran-
sients were detected in neuronal networks that were generated
from two independent CB-iNC lines (Fig. 3 B–D). Calcium
transients detected in CB-derived neurons were blocked after
the addition of glutamate receptor antagonists [6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; AMPA receptor antagonist)
and (2R)-amino-5-phosphonovaleric acid (APV; NMDA re-
ceptor antagonist); Fig. 3B] and after the addition of TTX (Fig.
3C), indicating that the recorded activities are specifically de-
pendent on local synaptic connections.
Whole-cell recording was performed on cells that had differ-
entiated 6 to 8 wk in coculture with human primary astrocytes. CB-
derived neurons were visualized by infection with the Synapsin::
DsRED or Synapsin::GFP lentiviral vector (Fig. 4A). CB-derived
neurons from distinct CB-iNC clones expressed functional voltage-
dependent sodium and potassium channels and were able to fire
action potentials after current injection (Fig. 4 B–D).
CB-Derived Neurons Engraft and Integrate into Mouse Hippocampus.
We next tested whether CB-derived neurons were able to in-
tegrate into existing neural networks in vivo. To this end, EGFP-
expressing CB-iNCs and CB-iNCs differentiated in coculture
with human astrocytes for 4 wk were injected into the hippo-
campus of 14-d-old NOD-SCID mice. We assayed for the pres-
ence of EGFP+ cells 2 wk, 1 mo, and 3 mo after transplantation.
As shown in Fig. S9, 2-wk transplanted cells expressed neuronal
markers TUJ-1 and NEUN and integrated within the host tissue.
The integrated CB-iNCs extended processes to endogenous
granule neurons of the dentate gyrus as well as along the mossy
fiber path to pyramidal neurons in the CA2/CA3 regions, and
were able to integrate along the corpus callosum, sending ex-
tensive TUJ-1+ processes to the contralateral hemisphere.
As a negative control, CB CD133+ cells infected only with
a constitutive EGFP lentivirus and transplanted into the hippo-
campus of 14-d-old mice were not able to differentiate into
neurons in vivo. They exhibited a round morphology with no
processes and were negative for TUJ-1 (Fig. 4E).
We found that, at 1 mo after transplantation, 90% of the CB-
derived neurons grafted were positive for TUJ-1 and 48% were
positive for the mature neuronal marker NEUN (Fig. 4 F–H). In
contrast, very few EGFP+ CB CD133+ cells survived in the
transplanted animals 4 wk after injection, further confirming that
CB CD133+ cells do not have intrinsic neurogenic potential
in vivo. Instead, CB-derived neurons survived at least 3 mo in the
transplantation site and developed long dendritic processes
bearing PSD95 puncta (Fig. S9D), suggestive of possible inter-
actions with the host cells. We performed electrophysiological
recordings on mouse brain sections 3 mo after transplantation
Fig. 3. Activity-dependent calcium transients in CB-derived
neurons. (A) Representative example of Syn::DsRed cultures
of CB-derived mature neurons used for calcium signal traces.
(Scale bar, 50 μm.) (B) Red traces correspond to the calcium
rise phase detected by the algorithm used (SI Materials and
Methods). Example of fluorescence intensity changes
reflecting intracellular calcium fluctuations in CB-derived
neurons before and after glutamate receptor antagonist
(CNQX/APV) treatment. Each number on the left corresponds
to the tracing of a different neuron on the plate. (C) Effects
of TTX (1 μM) and CNQX/APV (10 μM/20 μM) on intracellular
calcium transient frequency of individual neurons analyzed
simultaneously by calcium imaging. (D) Analysis of sponta-
neous intracellular calcium transients in CB-derived neurons
after 4 wk of differentiation. CB-derived neurons differen-
tiated from two distinct CB-iNCs showed similar prevalence
of calcium signaling as well as similar transient frequency
within the neuronal population. Data shown as mean ± SEM.








and found that GFP-positive CB-derived neurons were able to
fire action potentials (Fig. 4 I–K).
Although spontaneous or evoked postsynaptic current could
not be recorded, the electrophysiological recordings, together
with the calcium imaging data, strongly indicate that CB-derived
neurons exhibited functional neuronal properties in vitro and
in vivo.
Discussion
This study shows the direct conversion of a pure population of
human blood cells (CD45+/CD133+) into cells of the neuronal
lineage by forced expression of only one transcription factor.
Here we successfully demonstrate that cells from the mesoder-
mal lineage can be switched to an ectodermal fate.
A major concern associated with the direct conversion of so-
matic cells is that rare contaminating NP or NC cells could be
present in the starting population and selectively expanded when
culture under neural culture conditions. To exclude definitively
this possibility, we confirmed that our starting population did not
contain any cells positive for NP (Nestin, Sox1, Nkx2.2, GFAP)
and NC (Sox10 and p75) markers.
From a more mechanistic point of view, it has been described
that the use of iPSC transcription factors in lineage conversion
experiments might first induce the generation of an unstable
pluripotent state (10, 24). CB-iNCs were derived by forced ex-
pression of Sox2 in combination with human ES/iPSC condition
cultures; however, the omission of Oct4 during the conversion
process ruled out the possibility that intermediate pluripotent
stages were generated. Our data are in agreement with a recent
study by Han et al. that shows the direct conversion of mouse
fibroblasts into NSCs by forced expression of five transcription
factors, including Sox2, c-Myc, and Klf4, but not Oct4 (13).
Furthermore, we find that CB-iNCs exhibit a neuron-restricted
phenotype already at the earliest passages, which is consistent
with the strong activation of proneuronal markers such as PAX6,
NeuroD1, DCX, TUJ-1, MAP2, and NF. Instead, glial marker
expression was virtually absent in these clones. These data are
indicative that CB-iNCs contain a heterogeneous population of
neuronal-like cells at different stages of neuronal specification,
which show proliferative activity when cultured in permissive
condition culture. Accordingly, we show that CB-iNCs contain
a small population of neural progenitor-like cells that are ca-
pable of self-renewal and that may resemble the population of
(Nestin+/−/GFAP−/Sox2+/Dcx+) transient amplifying neuron-
restricted progeny recently described in adult hippocampal
neurogenesis (33). Furthermore, we show that CB-iNCs can
mature to the point of exhibiting functional neuronal properties
as judged by the measurement of action potential. Although CB-
iNCs exhibit a series of neural properties, including the ability
to engraft and differentiate into mature neurons after trans-
plantation, these cells could not generate spontaneous post-
synaptic activity. To this end, it is conceivable that further
optimization of the culturing conditions will lead to the gener-
ation of fully mature neurons. However, our data are perfectly in
line with previous works describing the derivation of human
iNCs (30, 34, 35), and support the idea that in general human
cells are less plastic and require longer maturation compared
with mouse cells (36, 37).
One strength of our protocol in comparison with others that
have achieved the direct conversion of human fibroblasts into
neurons is the advantage of generating a neural progenitor
population that can be further expanded and maturated in vitro.
The remarkable capability of a single factor to directly convert
CB cells into neuronal cells provides further evidence of the
plasticity of stem cell populations, which are much more ame-
nable to cell state transitions than somatic cells. This possibility is
further corroborated by the lack of neural induction from
CD133-negative fraction of CB by using the same approach.
These facts highlight the importance of the starting population.
It would be interesting to perform a side-by-side comparison
of the reprogramming into iNCs of CB cells vs. human fibroblasts
to understand the role of key transcription factors and to de-
terminate the impact of donor cell type. Thus, CB-iNCs provide
a complementary paradigm for the conduction of mechanistic
studies on transdifferentiation and drug screening, which nor-
Fig. 4. Electrophysiology and in vivo grafting of CB-derived neurons. (A)
Representative fluorescence micrograph of CB-derived neurons in culture
expressing Synapsin::DsRed. (Scale bar, 10 μm.) (BandC)Whole-cell recordings
obtained in vitro. (B) Transient Na+ currents and sustained K+ currents in re-
sponse to voltage step (cell voltage-clampedat−70mVwhile transient steps at
5-mV increments were applied). The trace highlighted in red was obtained in
response to a step of +45 mV from resting −70 mV. (C) Action potentials
evoked by somatic current injections (cell current-clamped at approximately
−70 mV, currents from 50 to 150 pA at 50-pA steps). (D) Spontaneous action
potentials when the cell was current-clamped at −60 mV. (E) CD133+ cells
grafted in the hippocampus, as controls, did not integrate into the host tissue
and did not express the neuronal markers TUJ-1 (arrow). (F) Representative
image of CB-derived neurons 4 wk after transplantation show increase in
colocalization with the mature neuronal marker NEUN (arrow). (Scale bars,
50 μm.) (G) Quantification of percentage of CB-derived neurons positive for
TUJ-1 and NEUN 4 wk after transplantation. (H) Detail of a GFP+ CB-derived
neuron 3 mo after transplantation shows extensive arborization and coloc-
alization with the mature neuronal marker NEUN. (Scale bar, 50 μm.) (I–K)
Whole-cell recordings obtained from a GFP+ CB-derived neuron 3 mo after its
transplantation in a young mouse hippocampus from cell represented in I
demonstrate that CB-derived neural progenitors can develop into functional
neurons and survive in the mouse brain. (J) Action potentials evoked by so-
matic current injections [cell current-clamped at approximately −70 mV (−2
pA) while increments of 2 pA were applied]. (K) Transient Na+ currents and
sustained K+ currents in response to voltage step (cell voltage-clamped at −70
mV while transient steps at 5-mV increments were applied). The traces high-
lighted in red were obtained in response to steps of +20 pA (J) or +45 mV (K).
12560 | www.pnas.org/cgi/doi/10.1073/pnas.1209523109 Giorgetti et al.
mally require a reproducible induction strategy along with rela-
tively high numbers of cells.
Materials and Methods
CD133+ Cell Purification. CB samples were obtained from the Banc de Sang i
Teixits, Hospital Duran i Reynals, Barcelona, Spain. Mononuclear cells were
isolated by using density gradient centrifugation. CD133+ cells were selected
by using an immunomagnetic separation system (Miltenyi Biotec). Purifica-
tion efficiency was verified by flow cytometric analysis staining with CD133
(phycoerythrin; Miltenyi Biotec) and CD45 (allophycocyanin; Becton Dick-
inson) antibodies. The CB CD133+ cells were infected and cultured as pre-
viously described (14, 23) (SI Materials and Methods).
CB-iNC Generation and Culture. CD133+ after infectionwere cultured on top of
HFF-1 in the presence of hES medium and 20 ng/mL bFGF (Peprotech). Three
weeks after infection, CB-iNC colonies started to appear. For expansion, CB-
iNC colonies were maintained on top of HFF-1 in the presence of hES medium
and 20 ng/mL bFGF (Peprotech) and picked mechanically every 7 d.
CB-iNC Differentiation into Mature Neurons. CB-iNCs were dissociated by using
trypsin, and 10,000 single cells were plated on human cerebellar astrocytes
(ScienCell) on polyornithine/laminin-coated plates in the presence of DMEM/
F12 plus N2 and B27 supplements, retinoic acid (1 μM), brain-derived neu-
rotrophic factor, glial cell line-derived neurotrophic factor (both at 20 ng/mL),
Lam (1 μg/mL), 200 nM ascorbic acid (Sigma), 1 mM dibutyryl-cAMP Lam
(1 μg/mL), and 0.5% FBS for 6 wk. For immunofluorescence assay, cells were
fixed in 4% (wt/vol) paraformaldehyde in PBS solution for 20 min. The
antibodies used to stain CB-derived neurons were TUJ-1 (1:500; Covance),
MAP2 (1:100; Sigma), VGLUT1 (1:200; Synaptic Systems), GABA (1:100;
Sigma), synapsin (1:400; Calbiochem), and EGFP (1:200; Invitrogene).
Functional in Vitro and in Vivo Studies. Similar methods were used for in vitro
culture experiments and ex vivo slice experiments. Individual coverslips or
slices for were transferred into a heated recording chamber and continuously
perfused (1 mL/min) with bubbled artificial cerebrospinal fluid maintained at
25 °C. For targeted whole-cell recordings, we used a 40× water-immersion
objective, differential interference contrast filters (Olympus), a digital cam-
era (Rolera XR; Qimaging), a halogen bulb (Olympus), a Digidata 1440A/
Multiclamp 700B amplifier and Clampex 10.3 software for analysis (Molec-
ular Devices). For measurement of voltage-gated Na+ currents, cells were
clamped at −70 mV and stimulated by step depolarizations of 300 ms
(command voltage from −55 to 0 mV in 5-mV steps). Cells were current
clamped at -70 mV to measure the spiking activities in response to somatic
current injections (duration of 300 ms, currents starting from 50 pA in 50-pA
increments). For ex vivo experiments, patching of deep GFP+ cells was also
assisted with a two-photon laser scanning system (FV1000MPE; Olympus).
The resistance of the patch electrodes was between 3 and 5 MΩ. Patch
electrodes were filled with internal solutions containing 130 mM K-gluco-
nate, 6 mM KCl, 4 mM NaCl, 10 mM Na-Hepes, 10 mM D-glucose, nucleotides
(0.3 mM GTP, 2 mM Mg-ATP, and 0.2 mM cAMP), 0.2 mM K-EGTA, 0.15%
biocytin, and 0.06% rhodamine. The pH and osmolarity of the internal so-
lution were close to physiological conditions (pH 7.3, 290–300 mOsm). Data
were all corrected for liquid junction potentials (10 mV). Electrode capaci-
tances were compensated online in cell-attached mode (∼7 pF). Recordings
were low-pass filtered at 2 kHz, digitized, and sampled at intervals of 50 μs
(20 kHz). To control the quality and the stability of the recordings
throughout the experiments, access resistance, capacitance, and membrane
resistance were continuously monitored online.
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